Adar1 Capital Management, LLC Day One Biopharmaceuticals, Inc. Transaction History
Adar1 Capital Management, LLC
- $539 Billion
- Q1 2025
A detailed history of Adar1 Capital Management, LLC transactions in Day One Biopharmaceuticals, Inc. stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 28,023 shares of DAWN stock, worth $190,556. This represents 0.04% of its overall portfolio holdings.
Number of Shares
28,023
Previous 53,023
47.15%
Holding current value
$190,556
Previous $672 Million
66.92%
% of portfolio
0.04%
Previous 0.13%
Shares
4 transactions
Others Institutions Holding DAWN
# of Institutions
196Shares Held
76.7MCall Options Held
138KPut Options Held
208K-
Atlas Venture Life Science Advisors, LLC6.43MShares$43.7 Million14.93% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.94MShares$40.4 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.76MShares$39.1 Million0.95% of portfolio
-
Black Rock Inc. New York, NY4.53MShares$30.8 Million0.0% of portfolio
-
Alyeska Investment Group, L.P. Chicago, IL4.06MShares$27.6 Million0.14% of portfolio
About Day One Biopharmaceuticals, Inc.
- Ticker DAWN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 73,461,104
- Market Cap $500M
- Description
- Day One Biopharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops and commercializes targeted therapies for patients with genetically defined cancers. Its lead product candidate is DAY101, an oral brain-penetrant type II pan-rapidly accelerated fibrosarcoma kinase inhibitor that is in Phase II clinical trial for pediatric pa...